Kalyani Commercials Ltd vs Q Line Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Kalyani Commercials Ltd is ₹ 144.99 as of 28 Aug 15:30 . The P/E Ratio of Kalyani Commercials Ltd changed from 5.2 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Kalyani Commercials Ltd changed from ₹ 11.93 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The Revenue of Kalyani Commercials Ltd is ₹ 0 crore as of Dec '25 .The Revenue of Q-Line Biotech Ltd is ₹ 90.03 crore as of Dec '25 . The EBITDA of Kalyani Commercials Ltd is ₹ 0 crore as of Dec '25 .The EBITDA of Q-Line Biotech Ltd is ₹ 30.54 crore as of Dec '25 . The Net Profit of Kalyani Commercials Ltd is ₹ 0 crore as of Dec '25 .The Net Profit of Q-Line Biotech Ltd is ₹ 17.38 crore as of Dec '25 . The Dividend Payout of Kalyani Commercials Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Kalyani Commercials Ltd

Kalyani Commercials Limited was incorporated in July, 1985.
Company has obtained a Certificate of Registration from the Reserve Bank of India as Non-Banking Finance Company; vide Registration No 14.00928 dated June 2, 1998. During the year 2017, Ganganagar Vehicles Private Limited became a subsidiary of the company with effect from 28th November 2016. During the year 2017, Nekub Consultancy Limited and YYKS Buildcon Limited became wholly owned subsidiaries with effect from 15th March 2017 respectively.
Company had 5 branches in Delhi and Kota both in FY 2017.
In 2019, Company had 3 branches named, Ganganagar Motors (Kota), BPCL Filling Station and GD Automobiles in Rajasthan and Haryana both. The Company is actively engaged in the trading of Heavy Commercial Vehicles, Three Wheelers, and provides servicing for these vehicles as an authorized dealership of TATA and Bajaj.

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

FAQs for the comparison of Kalyani Commercials Ltd and Q-Line Biotech Ltd

Which company has a larger market capitalization, Kalyani Commercials Ltd or Q-Line Biotech Ltd?

Market cap of Kalyani Commercials Ltd is 14 Cr while Market cap of Q-Line Biotech Ltd is 1,235 Cr

What are the key factors driving the stock performance of Kalyani Commercials Ltd and Q-Line Biotech Ltd?

The stock performance of Kalyani Commercials Ltd and Q-Line Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kalyani Commercials Ltd and Q-Line Biotech Ltd?

As of October 25, 2026, the Kalyani Commercials Ltd stock price is INR ₹144.99. On the other hand, Q-Line Biotech Ltd stock price is INR ₹529.55.

How do dividend payouts of Kalyani Commercials Ltd and Q-Line Biotech Ltd compare?

To compare the dividend payouts of Kalyani Commercials Ltd and Q-Line Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.